Open Access is an initiative that aims to make scientific research freely available to all. To date our community has made over 100 million downloads. It’s based on principles of collaboration, unobstructed discovery, and, most importantly, scientific progression. As PhD students, we found it difficult to access the research we needed, so we decided to create a new Open Access publisher that levels the playing field for scientists across the world. How? By making research easy to access, and puts the academic needs of the researchers before the business interests of publishers.
We are a community of more than 103,000 authors and editors from 3,291 institutions spanning 160 countries, including Nobel Prize winners and some of the world’s most-cited researchers. Publishing on IntechOpen allows authors to earn citations and find new collaborators, meaning more people see your work not only from your own field of study, but from other related fields too.
To purchase hard copies of this book, please contact the representative in India:
CBS Publishers & Distributors Pvt. Ltd.
www.cbspd.com
|
customercare@cbspd.com
Provident Clinical Research, Biofortis North America, United States of America
M. Rains Tia
Provident Clinical Research, Biofortis North America, United States of America
*Address all correspondence to:
1. Introduction
The prevalence of type 2 diabetes mellitus (T2DM) continues to increase at an alarming rate. Approximately 18.8 million people in the United States have diagnosed diabetes, whereas 7.0 million people are estimated to be living with the disease undiagnosed (Centers for Disease Control and Prevention [CDC], 2011). Another 79 million adults 20 years and older have pre-diabetes: impaired glucose tolerance (IGT) and/or impaired fasting glucose (IFG) (CDC, 2011). Approximately 20-30% of individuals with pre-diabetes progress to T2DM within 3-4 years (DeFronzo et al., 2011; Knowler et al., 2002).
The progression from normal glucose tolerance to the onset of T2DM is protracted and preceded by metabolic abnormalities that ultimately lead to hyperglycemia. Early in the disease process, individuals typically exhibit resistance to insulin-stimulated glucose uptake at the cellular level (Reaven et al., 2005). Insulin resistance is also associated with a cluster of metabolic disorders including central obesity, dyslipidemia and hypertension that are risk factors for T2DM and atherosclerotic cardiovascular disease (Alexander et al., 2000). The aggregation of these disorders is often referred to as metabolic syndrome or cardiometabolic syndrome (Reaven et al., 2005).
Insulin resistance manifests as decreased insulin-stimulated glucose uptake at adipose and skeletal muscle tissues, as well as impaired suppression of hepatic glucose output by a given circulating level of insulin (DeFronzo, 2009; Goldstein 2003). Normal glucose tolerance is maintained via compensatory hyperinsulinemia, thus preventing hyperglycemia in the earliest stages (Reaven et al., 2005). Over time, the pancreatic beta-cell response becomes inadequate to maintain normoglycemia, and hyperglycemia ensues. It is unclear whether there is an exhaustion of the beta-cells, or if the beta-cells become progressively less responsive to the changes in circulating glucose, or a combination of these defects (Ferannini et al., 2005; Butler et al., 2003; Khan, 2001). Regardless, progressive beta-cell dysfunction ultimately leads to an inability to secrete sufficient insulin to maintain normoglycemia after a carbohydrate load. In frank T2DM, insulin secretion becomes sufficiently impaired to result in hyperglycemia in the fasting state (Stolar, 2010). By the time T2DM is diagnosed, the insulin secretory response is generally 70-80% below that which would be appropriate for the prevailing level of insulin resistance (Ferannini et al., 2005; Maki et al., 2009). The interplay between insulin resistance and beta-cell dysfunction in the development of T2DM (DeFronzo, 2009; Khan 2001) and methods of assessing insulin sensitivity in clinical research (Muniyappa et al., 2008; Singh 2010) have been reviewed in detail elsewhere.
Diabetes prevention trials have shown that interventions which increase insulin sensitivity significantly reduce the rate of conversion to diabetes in high risk individuals (Knowler et al., 2002; Tuomilehto et al., 2001; Lindstrom et al., 2003; Pan et al., 1997; Zinman et al., 2010; DeFronzo et al., 2011). In the Diabetes Prevention Program, a lifestyle intervention with targets of 150 minutes per week of moderate intensity physical activity and weight loss of 7% reduced the rate of progression to diabetes by 58% relative to a group that received placebo without lifestyle intervention (Knowler et al., 2002), which was greater than the 31% reduction in new-onset diabetes with metformin treatment. Other lifestyle intervention studies of weight loss and enhanced physical activity have shown reductions in the incidence of new-onset type 2 diabetes of 25-60% over 3-6 year timeframes in individuals with pre-diabetes (Lindstrom et al., 2003; Pan et al., 1997). Both weight loss and increased physical activity enhance insulin sensitivity, which results in a reduced requirement for insulin secretion, thus “unloading” the beta-cells. In turn, this may extend the time during which the available insulin secretory response can maintain normoglycemia. In addition, there is evidence that some interventions that improve insulin sensitivity may arrest, or even partially reverse, the progression of beta-cell dysfunction (Utzschneider et al., 2008; Gastaldelli et al., 2007).
Although weight loss and increased physical activity have received the most attention, particularly in clinical intervention trials, a number of other lifestyle factors may have important influences on the risk for T2DM. Dietary patterns characterized by high intakes of fruits and vegetables, whole grains, low-fat dairy products, and a low glycemic load have been inversely associated with T2DM risk (Figure). In contrast, dietary patterns characterized by high intakes of processed meats, refined grains, and foods containing high
Figure 1.
Relative risks for the associations between cereal fiber, fruit fiber, and vegetable fiber with risk of type 2 diabetes mellitus. Adapted from Schulze et al. 2007. CI = confidence interval.
Whole grains contain a number of constituents that may influence T2DM risk, including fibers, vitamins, minerals, lignans, and phytochemicals. The focus of this review is on the potential influences of dietary fibers on risk for T2DM, and the mechanisms that may account for these associations. Nevertheless, the reader should keep in mind that dietary fiber intake correlates with a number of other dietary and lifestyle factors that may influence risk for T2DM, thus fiber intake is likely only one component of the apparent protective effect of a low-risk eating pattern.
Greater consumption of dietary fiber is associated with lower risk for the development of T2DM, and this may explain, at least in part, the relationship between consumption of whole grains and diabetes risk (Björck& Elmståhl, 2003). Previously, it was thought the reduction in risk might be attributable to the consumption of viscous soluble fibers such as beta-glucan, psyllium, and pectin. Such fibers form viscous solutions when mixed with fluid in the gastrointestinal (GI) tract, creating a physical barrier to digestive enzymes and through which simple sugars must travel to reach the intestinal brush border for absorption (Dikeman & Fahey, 2006; Wolever, 1991; Jenkins et al., 1978). As such, postprandial glucose responses are attenuated when viscous fibers are consumed as part of carbohydrate-rich meals, effectively lowering the glycemic index of such foods (Jenkins et al., 2000, Maki et al., 2007). Prospective epidemiological and observational studies have shown associations between intakes of high-glycemic index foods and high-glycemic load diets and a greater risk of T2DM, consistent with this potential mechanism (Biesalski 2004, Salmeron et al., 1997a, 1997b).
However, results from prospective cohort studies have shown that consumption of insoluble cereal fibers is more strongly inversely associated with risk of T2DM than consumption of soluble fibers (McKeown et al., 2004; Schulze et al., 2007; Weickert & Pfeiffer, 2008). For example, in a cohort of ~25,000 men and women ages 35 to 65 years, greater intake of cereal fibers, but not fruit or vegetable fibers, was inversely associated with developing diabetes over an 11 year period after adjusting for lifestyle and dietary confounders (Schulze et al., 2007). Similarly, a meta-analysis of nine cohort studies on fiber also showed an inverse association for cereal fiber and T2DM risk, but not other fibers (Schulze et al., 2007). Most sources of dietary fiber contain both soluble and insoluble fiber in varying amounts, but whole grain products generally contain a high proportion of insoluble cereal fiber (Weickert & Pfeiffer, 2008; McKee & Latner, 2000). In the U.S. diet, the main sources of soluble fiber are fruits and vegetables, and to a smaller extent, oats and barley (McKee & Latner, 2000).
4. Dietary fiber, colonic fermentation and T2DM risk
Results from several recent studies suggest that fermentability may be a more important factor in the association between dietary fiber intake and T2DM risk than solubility or viscosity. In particular, there is accumulating evidence for a metabolic link between consumption of fibers which are fermented in the lower intestine and insulin sensitivity. This relationship appears likely to be mediated, at least in part, by the inverse association between short chain fatty acid (SCFA) and free fatty acid (FFA) levels in circulation (Robertson et al, 2003, 2005).
Elevated levels of circulating FFA are associated with insulin resistance and it is thought that they contribute to reduced insulin action in the skeletal muscle and liver (Kim et al, 2007). FFA disrupt glucose metabolism by enhancing beta-oxidation in peripheral tissues and by competing with glucose for oxidation, resulting in a reduction of peripheral glucose uptake (Tarini & Wolever, 2010). Sustained elevation of FFA, induced through intravenous infusion of a lipid emulsion, down regulates glycogen storage and leads to a reduction of non-oxidative glucose disposal, thus reducing insulin sensitivity (Ferrannini et al., 1983; Kashyap et al., 2003; Homko et al., 2003). Potential mechanisms by which FFA might affect glycogen regulation include increased expression and activation of glucose-6-phosphatase (Clore et al., 2000; Van de Werve et al., 2000). Conversely, suppression of FFA levels with an infusion of acipimox, a niacin derivative that inhibits hormone sensitive lipase, improves glucose tolerance and peripheral insulin sensitivity (Ferrannini et al., 1983).
The release of FFA shows diurnal variation and is correlated with hepatic glucose output during sleep (Morgan et al., 1999, Kim et al., 2007). In normal weight individuals the fall of hepatic glucose output during sleep is highly synchronized with a decrease in FFA levels (Clore et al., 1989). Conversely, T2DM subjects have an increased rate of FFA appearance at night and elevated plasma FFA levels that are correlated with increased overnight hepatic glucose output (Miles et al., 2003; Taskinen et al., 1989). This increase in FFA levels and release of insulin can be acutely reduced with a pharmacological block of lipoloysis, suggesting that a reduction in FFA release may lead to improved glucose homeostasis (Andreotti et al., 1994). In the canine model of moderate obesity, an increase in nocturnal FFA levels and reduced insulin sensitivity occurred after 6 weeks of high-fat feeding, despite no changes in fasting FFA, fasting glucose or postprandial glucose levels, providing further support that the overnight period may be particularly important (Kim et al., 2007). Given the known diurnal fluctuations of FFA observed in overweight and obese subjects, and in the moderately obese canine model, it is likely that the nocturnal increase in FFA is a key factor in the development of insulin resistance and may play a significant role in the risk for T2DM.
Consumption of indigestible fibers provides available substrate for resident microbiota in the large intestine, which form fermentation products, particularly SCFA (acetate, butyrate, and propionate). Upon absorption into the circulation, SCFA suppress the release of FFA from adipose tissue, thus lowering the concentrations of FFA in circulation, which, in turn, could lead to improved insulin sensitivity and concomitant reduced risk for T2DM (Tarini & Wolever, 1991).
Feeding studies in humans support this proposed relationship between colonic fermentation and peripheral metabolic effects (Table). Nilsson et al. (2008) provided healthy subjects evening meals containing a variety of cereal-based foods with varying levels of resistant starch and fermentable fiber. They demonstrated a relationship between colonic fermentation, as measured by breath hydrogen, and glucose tolerance at the subsequent breakfast meal more than nine hours later (Nilsson et al., 2008). Compared to white bread in the evening, consumption of bread made with barley kernels, high beta-glucan barley, or white bread supplemented with resistant starch and barley fiber all reduced the postprandial curves for glucose and insulin after a subsequent standard breakfast, consistent with improved insulin sensitivity. Additionally, the glucose response was inversely associated with SCFA concentrations (butyrate and acetate) and was positively correlated with FFA during the postprandial period.
Several studies have demonstrated enhanced insulin sensitivity, measured with the euglycemic clamp (the reference standard method) or other methods, after consumption of fermentable fibers or resistant starches over periods ranging from several hours to several weeks (Landin et al., 1988; Robertson et al., 2003, 2005; Maki et al., 2011). Landin et al. (1988) showed improved insulin sensitivity in healthy, nonobese men measured by euglycemic-clamp following intake of 30 g/d guar gum. More recently, Robertson et al (2003) examined the role of resistant starch (RS) on insulin sensitivity in healthy subjects following a 60 g load of RS consumed over the course of one day. Increased insulin sensitivity was positively associated with fasting breath hydrogen levels and lower FFA levels in the late postprandial period (Robertson et al., 2003). In a subsequent study comparing 30 g RS/day for four weeks versus a control starch, insulin sensitivity during a meal tolerance test was 33% higher and glucose clearance adjusted for insulin concentration was 44% higher following RS intake compared with the control condition. Insulin sensitivity, as measured by the euglycemic-hyperinsulinemic clamp, was also higher following RS (Robertson et al., 2005). In a chronic (12-week) study in insulin resistant subjects, 40 g RS/day (supplied in sachets to mix into their daily foods) was associated with improved insulin sensitivity compared to placebo (Johnston et al., 2010). Insulin sensitivity was also correlated with changes in waist circumference, however there was no difference in body mass index, total adipose tissue content or regional distribution between the groups suggesting the observed improvement in insulin sensitivity is not directly attributable to changes in body composition (Johnston et al., 2010). In a study of overweight and obese subjects with normal glucose metabolism, Weikert et al. (2006) reported a 13% improvement in insulin sensitivity in subjects who consumed white bread supplemented with 31.2 g/d insoluble fiber fraction from oat fiber over 72 hours, compared to a white bread control.
Not all studies have shown favorable effects of fermentable fibers on insulin sensitivity. Ebeling et al. (1988) studied the effects of 5 g/d guar gum for 4 weeks in individuals with type 1 diabetes mellitus and showed that guar gum lowered the postprandial glucose response and reduced insulin requirements, suggesting an improvement in hepatic insulin sensitivity. However, there was no measurable effect on peripheral insulin sensitivity, as measured by euglycemic insulin clamp. Given that this study was small (n = 9), a type II error (lack of power) cannot be ruled out. A study in 21 men with metabolic syndrome also failed to show differences in insulin sensitivity measured by euglycemic insulin clamp following a 5-week dietary intervention with 28 g/day of acacia gum and pectin (Pouteau et al., 2010).
Authors
Study Population
Design
Study Products
Results
Andersson et al., 2007
Healthy volunteers (n=30) Age (y): 59+5 BMI (kg/m2): 28.3+2.0
Randomized crossover 6-week study of diet rich in whole grains vs. diet containing equal amount of refined grain
Whole grain diet contained 112 g/d of whole grain, 18 g fiber Refined grain diet contained 6 g/d fiber
No effect of whole grains on insulin sensitivity
Ebeling et al., 1988
Type 1 diabetics (n=9) Age (y): 27+2 Body Weight (kg): 71+3
Double-blind crossover with two 4-week study periods
A dietary pattern characterized by high intakes of whole grains, fruits and vegetables, low-fat dairy products, and a low glycemic load has been associated with lower T2DM risk. Whole grains possess a number of constituents that may influence T2DM risk, including vitamins, minerals, lignans and phytochemicals. Greater dietary fiber intake is also associated with lower risk for the development of T2DM, and this may explain, at least in part, the relationship between consumption of whole grains and reduced diabetes risk. Results from recent intervention studies suggest that fermentability may be the key characteristic of fibers associated with improved insulin sensitivity, providing a metabolic link between dietary fiber intake and reduction in T2DM risk. Future studies on the relationships between dietary fiber, production of SCFAs, circulating FFA release, and physiological mediators such as incretins (glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide), and inflammatory markers (e.g., interleukin-6, adiponectin), are warranted. There is also a need for longer-term intervention trials to determine the mechanisms by which dietary fibers, particularly fermentable fibers, influence health and T2DM risk.
References
1.AlexanderC. M.LandsmanP. B.TeutschS. M.2000 Diabetes mellitus, impaired fasting glucose, atherosclerotic risk factors, and prevalence of coronary heart disease. American Journal of Cardiology,869897902 . 0002-9149
2.AnderssonA.TengbladS.KarlströmB.Kamal-EldinA.LandbergR.BasuS.ÅmanP.VessbyB.2007Whole-grain foods do not affect insulin sensitivity or markers of lipid peroxidation and inflammation in healthy, moderately overweight subjects, The Journal of Nutrition, 137614011407 . 0022-3166
3.AndreottiA. C.LanziR.ManzoniM. F.CaumoA.MoreschiA.PontiroliA. E.1994Acute pharmacologic blockade of lipolysis normalizes nocturnal growth hormone levels and pulsatility in obese subjects. Metabolism, 431012071213 . 0026-0495
4.BergmanR. N.KimS. P.HsuI. R.CatalanoK. J.ChiuJ. D.KabirM.RicheyJ. M.AderM.2007Abdominal obesity role in the pathophysiology of metabolic disease and cardiovascular risk.The American Journal of Medicine, 1202AS3S8 . 0002-9343
5.BiesalskiH.K.2004Diabetes preventive components in the Mediterranean diet.European Journal of Nutrition., 43 1 l/2630. 1436-6207
6.BjörckI.ElmståhlH. L.2003The glycaemic index: importance of dietary fibre and other food properties.Proceedings of the Nutrition Society, 621201206 . 0029-6651
7.BrunnerE. J.MosdølA.WitteD. R.MartikainenP.StaffordM.ShipleyM. J.MarmotM. G.2008Dietary patterns and 15-y risks of major coronary events, diabetes, and mortality. American Journal of Clinical Nutrition. 87514141421 . 0002-9165
8.ButlerA. E.JansonJ.Bonner-WeirS.RitzelR.RizzaR. A.ButlerP. C.2003Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes.Diabetes. 521102110 . 0012-1797
9.Center for Disease Control and Prevention.National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States, 2011 Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention
10.CloreJ. N.NestlerJ. E.BlackardW. G.1989Sleep-associated fall in glucose disposal and hepatic glucose output in normal humans. Putative signaling mechanism linking peripheral and hepatic events.Diabetes, 383285290 . 0012-1797
11.CloreJ. N.StillmanJ.SugermanH.2000Glucose-6-phosphatase flux in vitro is increased in type 2 diabetes.Diabetes , 496969974 . 0012-1797
12.DefronzoR.A.2009Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus.Diabetes. 58773795 . 0012-1797
13.De FronzoR. A.TripathyD.SchwenkeD. C.BanerjiM.BrayG. A.BuchananT. A.ClementS. C.HenryR. R.HodisH. N.KitabchiA. E.MackW. J.MudaliarS.RatnerR. E.WilliamsK.StentzF. B.MusiN.ReavenP.2011Pioglitazone for diabetes prevention in impaired glucose tolerance. New England Journal of Medicine, 3641211041115 . 0028-4793
14.de MunterJ. S.HuF. B.SpiegelmanD.FranzM.van DamR. M.2007 Whole grain, bran, and germ intake and risk of type 2 diabetes: a prospective cohort study and systemic review. PLoS Medicine,48e2611549-1277
15.DikemanC.L.Fahey G.C. Viscosity as related to dietary fiber: a review. 2006Critical Reviews in Food Science and Nutrition,468649663 . 1040-8398
16.EbelingP.Yki-JärvinenH.AroA.HelveE.SinisaloM.KoivistoV. A.1988Glucose and lipid metabolism and insulin sensitivity in type 1 diabetes: the effect of guar gum.The American Journal of Clinical Nutrition, 48198103 . 0002-9165
17.FerranniniE.GastaldelliA.MiyazakiY.MatsudaM.MariA.De FronzoR. A.2005beta-Cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: a new analysis.Journal of Clinical Endocrinology and Metabolism. 901493500 . 0002-1972X
18.FerranniniE.BarrettE. J.BevilacquaS.De FronzoR. A.1983Effect of fatty acids on glucose production an utilization in man.Journal of Clinical Investigation, 72517371747 . 0021-9738
19.FungT. T.Mc CulloughM.van DamR. M.HuF. B.2008A prospective study of overall diet quality and risk of type 2 diabetes in women.Diabetes Care. 30717531757 . 0149-5992
20.GastaldelliA.FerranniniE.MiyazakiY.MatsudaM.MariA.De FronzoR. A.2007Thiazolidinediones improve beta-cell function in type 2 diabetic patients.American Journal of Physiology- Endocrinology and Metabolism, 2923E871E883 . 0193-1849
21.GittelsohnJ.WoleverT. M.HarrisS. B.Harris-GiraldoR.HanleyA. J.ZinmanB.1998Specific patterns of food consumption and preparation are associated with diabetes and obesity in a Native Canadian community.Journal of Nutrition,1283541547 . 0022-3166
22.GoldsteinB.B.2003Insulin resistance: from benign to type 2 diabetes mellitus.Reviews Cardiovascular Medicine,4 6S3S101530-6550
23.HeidemannC.HoffmannK.SprangerJ.Klipstein-GrobuschK.MöhligM.PfeifferA. F.BoeingH.2005A dietary pattern protective against type 2 diabetes in the European Prospective Investigation into Cancer and Nutrition (EPIC)- Potsdam Study cohort.Diabetologia, 48611261134 . 0001-2186X
24.HodgeA. M.EnglishD. R.O’DeaK.GilesG. G.Dietary patterns and diabetes incidence in the Melbourne Collaborative Cohort Study. 2007American Journal of Epidemiology, 1656603610 . 0002-9262
25.HomkoC. J.CheungP.BodenG.2003Effects of free fatty acids on glucose uptake and utilization in healthy women.Diabetes, 522487491 . 0012-1797
26.JenkinsD. J.WoleverT. M.LeedsA. R.GassullM. A.HaismanP.DilawariJ.GoffD. V.MetzG. L.AlbertiK. G.1978Dietary fibres, fibre analogues, and glucose tolerance: importance of viscosity.British Medical Journal, 27113921394 . 0959-8138
27.JenkinsD. J.AxelsenM.KendallC. W.AugustinL. S.VuksanV.SmithU.2000Dietary fibre, lente carbohydrates and the insulin-resistant diseases.British Journal of Nutrition,83 1S157S163 . 0007-1145
29.KastoriniC.M.PanagiotakosD.B.2009Dietary patterns and prevention of type 2 diabetes: from research to clinical practice: a systematic review. Current Diabetes Reviews, 54221227 . 1573-3998
30.KashyapS.BelfortR.GastaldelliA.PratipanawatrT.BerriaR.PratipanawatrW.BajajM.MandarinoL.De FronzoR.CusiK.2003A sustained increase in plasma free fatty acids impairs insulin secretion in nondiabetic subjects genetically predisposed to develop type 2 diabetes.Diabetes, 521024612474 . 0012-1797
31.KhanS. E.2001 The importance of beta-cell failure in the development and progression of type 2 diabetes. Journal of Clinical Endocrinology & Metabolism, 86940474058 . 0002-1972X
32.KimS. P.CatalanoK. J.HsuI. R.ChiuJ. D.RicheyJ. M.BergmanR. N.2007Nocturnal free fatty acids are uniquely elevated in the longitudinal development of diet-induced insulin resistance and hyperinsulinemia.American Journal of Physiology- Endocrinology and Metabolism, 2926E1590E1598 . 0193-1849
33.KnowlerW. C.Barrett-ConnorE.FowlerS. E.HammanR. F.LachinJ. M.WalkerE. A.NathanD. M.2002Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.New England Journal of Medicine,3466393403 . 0028-4793
34.LandinK.HolmG.TengbornL.SmithU.1992Guar gum improves insulin sensitivity, blood lipids, blood pressure, and fibrinolysis in healthy men. The American Journal of Clinical Nutrition, 56610611065 . 0002-9165
35.LindströmJ.ErikssonJ. G.ValleT. T.AunolaS.CepaitisZ.HakumäkiM.HämäläinenH.Ilanne-ParikkaP.Keinänen-KiukaanniemiS.LaaksoM.LouherantaA.MannelinM.MartikkalaV.MoltchanovV.RastasM.SalminenV.SundvallJ.UusitupaM.TuomilehtoJ.2003Prevention of diabetes mellitus in subjects with impaired glucose tolerance in the Finnish Diabetes Prevention Study: results from a randomized clinical trial. Journal of the American Society of Nephrology, 147 Suppl 2 S108S113 . 1046-6673
36.LiuS.MansonJ. E.StampferM. J.HuF. B.GiovannucciE.ColditzG. A.HennekensC. H.WillettW. C.2000A prospective study of whole-grain intake and risk of type 2 diabetes mellitus in US women.American Journal of Public Health, 90914091415 . 1541-0048
37.MakiK. C.Mc KenneyJ. M.FarmerM. V.ReevesM. S.DicklinM. R.2009Indices of insulin sensitivity and secretion from a standard liquid meal test in subjects with type 2 diabetes, impaired or normal fasting glucose.Nutrition Journal. 28822 . 1475-2891
38.MakiK. C.CarsonM. L.MillerM. P.TurowskiM.BellM.WilderD. M.ReevesM. S.2007High-viscosity hydroxypropylmethylcellulose blunts postprandial glucose and insulin responses.Diabetes Care, 30510391043 . 0149-5992
39.MakiK. C.PelkmanC. L.KelleyK. M.LawlessA. L.SchildA.RainsT. M.2011 Effects of type 2 resistant starch consumption on insulin sensitivity in men and women. Experimental Biology. Abstract 2914
40.McKeeL.H.LatnerT.A.2000Underutilized sources of dietary fiber: a review. Plant Foods for Human Nutrition, 554285304 . 0921-9668
41.McKeownN.M.2004Whole grain intake and insulin sensitivity: evidence from observational studies.Nutrition Reviews, 62 7 Pt 1), 286291 . 0029-6643
42.MilesJ. M.WooldridgeD.GrellnerW. J.WindsorS.IsleyW. L.KleinS.HarrisW. S.2003Nocturnal and postprandial free fatty acid kinetics in normal and type 2 diabetic subjects: effects of insulin sensitization therapy.Diabetes, 523675681 . 0012-1797
43.MontonenJ.KnektP.HärkänenT.JärvinenR.HeliövaaraM.AromaaA.Reunanen. A.2005Dietary patterns and the incidence of type 2 diabetes. American Journal of Epidemiology,16132192270002-9262
44.MorganL. M.AspostolakouF.WrightJ.GamaR.1999 Diurnal variations in peripheral insulin resistance and plasma non-esterified fatty acid concentrations: a possible link? Annals of Clinical Biochemistry,364447450 . 0004-5632
45.MuniyappaR.LeeS.ChenH.QuonM. J.2008Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. American Journal of Physiology, Endocrinology, and Metabolism.2941E15E26 . 19318-4915
46.MurtaughM. A.JacobsD. R. Jr JacobB.SteffenL. M.MarquartL.2003Epidemiological support for the protection of whole grains against diabetes.Proceedings of the Nutrition Society,621143149 . 0029-6651
47.NilssonA. C.ÖstmanE. M.HolstJ. J.BjörckM. E.2008Including indigestible carbohydrates in the evening meal of healthy subjects improves glucose tolerance, lowers inflammatory markers, and increases satiety after a subsequent standardized breakfast. The Journal of Nutrition, 1384732739 . 0022-3166
48.PanX. R.LiG. W.HuY. H.WangJ. X.YangW. Y.AnZ. X.HuZ. X.LinJ.XiaoJ. Z.CaoH. B.LiuP. A.JiangX. G.JiangY. Y.WangJ. P.ZhengH.ZhangH.BennettP. H.HowardB. V.1997Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study.Diabetes Care, 204537544 . 0149-5992
49.PouteauE.Ferchaud-RoucherV.ZairY.PaintinM.EnslenM.AuriouN.MacéK.GodinJ. P.BallèvreO.KrempfM.2010Acetogenic fibers reduce fasting glucose turnover but not peripheral insulin resistance in metabolic syndrome patients. Clinical Nutrition, 296801807 . 1202-3884
50.ReavenG. M.2005The insulin resistance syndrome: definition and dietary approaches to treatment.Annual Reviews of Nutrition, 25392406 . 0199-9885
51.RobertsonM. D.BickertonA. S.DennisA. L.VidalH.FraynK. N.2005 Insulin-sensitizing effects of dietary resistant starch and effects on skeletal muscle and adipose tissue metabolism. The American Journal of Clinical Nutrition,823559567 . 0002-9165
53.SalmerónJ.AscherioA.RimmE. B.ColditzG. A.SpiegelmanD.JenkinsD. J.StampferM. J.WingA. L.WillettW. C.1997 aDietary fiber, glycemic load, and risk of NIDDM in men.Diabetes Care, 204545550 . 0149-5992
54.SalmerónJ.MansonJ. E.StampferM. J.ColditzG. A.WingA. L.WillettW. C.1997b Dietary fiber, glycemic load, and risk of non-insulin-dependent diabetes mellitus in women.Journal of the American Medical Association,2776472477 . 0098-7484
55.SchulzeM. B.SchulaM.HeidemannC.SchienkiewitzA.HoffmanK.BoeingH.2007Fiber and magnesium intake and incidence of type 2 diabetes: a prospective study and meta-analysis.Archives of Internal Medicine, 1679956965 . 0003-9926
56.SinghB.SaxenaA.2010Surrogate markers of insulin resistance: A review.World Journal of Diabetes. 123647 . 1948-9358
57.StolarM.2010Glycemic control and complications in type 2 diabetes mellitus. American Journal of Medicine, 1233S3S11 . 0002-9343
58.TariniJ.WoleverT. M. S.2010The fermentable fibre inulin increases postprandial serum short-chain fatty acids and reduces free-fatty acids and ghrelin in healthy subjects. Applied Physiology Nutrition and Metabolism, 351916 . 1715-5320
59.TaskinenM. R.SaneT.HelveE.KaronenS. L.NikkilaE. A.Yki-JarvinenH.1989Bedtime insulin for suppression of overnight free-fatty acid, blood glucose, and glucose production in NIDDM.Diabetes, 385580588 . 0012-1797
60.TuomilehtoJ.LindströmJ.ErikssonJ. G.ValleT. T.HämäläinenH.Ilanne-ParikkaP.Keinänen-KiukaanniemiS.LaaksoM.LouherantaA.RastasM.SalminenV.UusitupaM.2001Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. New England Journal of Medicine, 3441813431350 . 0028-4793
61.UtzschneiderK. M.TongJ.MontgomeryB.UdayasankarJ.GerchmanF.MarcovinaS. M.WatsonC. E.Ligueros-SaylanM. A.FoleyJ. E.HolstJ. J.DeaconC. F.KahnS. E.2008The dipeptidyl peptidase-4 inhibitor vildagliptin improves beta-cell function and insulin sensitivity in subjects with impaired fasting glucose.Diabetes Care, 311108113 . 0022-3166
62.van DamR. M.WillettW. C.RimmE. B.StampferM. J.HuF. B.2002Dietary fat and meat intake in relation to risk of type 2 diabetes in men.Diabetes Care, 253417424 . 0149-5992
63.Van de WerveW. G.LangeA.NewgardC.MechinM. C.LiY.BertelootA.2000New lessons in the regulation of glucose metabolism taught by the glucose 6-phosphatase system. European Journal of Biochemistry, 26715331549 . 0014-2956
64.WeickertM. O.MöhligM.SchöflC.ArafatA. M.OttoB.ViehoffH.KoebnickC.KohlA.SprangerJ.PfeifferA. F. H.2006Cereal fiber improves whole-body insulin sensitivity in overweight and obese women.Diabetes Care, 294775780 . 0149-5992
65.Weickert M.O.PfeifferA.F.H.2008Metabolic effects of dietary fiber consumption and prevention of diabetes. The Journal of Nutrition, 1383439442 . 0022-3166
66.WilliamsD. E.PrevostA. T.WhichelowM. J.CoxB. D.DayN. E.WarehamN. J.2000A cross-sectional study of dietary patterns with glucose intolerance and other features of the metabolic syndrome.British Journal of Nutrition. 833257266 . 0007-1145
67.WoleverT.M.1991Small intestinal effects of starchy foods.Canadian Journal of Physiology and Pharmacology, 6919399 . 0008-4212
Written By
Kevin C. Maki and Tia M. Rains
Submitted: 16 November 2010Published: 04 November 2011